- JP-listed companies
- SENJU PHARMACEUTICAL CO.,LTD.
- Income statement
SENJU PHARMACEUTICAL CO.,LTD.【JP:E00965】Income statement
Market cap
P/E ratio
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 25,109 | 28,687 | 33,308 | 35,052 | 37,794 | 37,914 | 37,095 | 40,906 | 41,215 | 40,778 | 40,887 | 46,407 | 48,970 | 48,917 |
| Cost of revenue | - | - | - | 10,406 | 10,398 | 10,143 | 9,544 | 10,154 | 10,414 | 10,598 | 11,726 | 13,362 | 14,613 | 16,599 |
| Gross profit | - | - | - | 24,646 | 27,396 | 27,771 | 27,551 | 30,752 | 30,800 | 30,180 | 29,161 | 33,045 | 34,357 | 32,318 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating expenses | - | - | - | 22,125 | 24,849 | 25,554 | 27,324 | 28,759 | 28,590 | 24,732 | 22,172 | 25,618 | 27,200 | 29,895 |
| Operating income | - | - | - | 2,521 | 2,547 | 2,217 | 227 | 1,994 | 2,211 | 5,449 | 6,989 | 7,427 | 7,157 | 2,423 |
| Income before tax | 4,315 | 2,483 | 4,888 | 7,099 | 6,996 | 5,541 | 3,165 | 4,967 | 4,365 | 8,086 | 9,126 | 8,759 | 9,147 | 2,939 |
| Provision for income taxes | - | - | - | 2,302 | 1,780 | 1,409 | 1,157 | 1,191 | 534 | 2,157 | 3,605 | 1,900 | 2,305 | 843 |
| Net income | - | - | - | 4,767 | 4,699 | 3,255 | 828 | 3,786 | 3,973 | 5,846 | 7,903 | 6,689 | 7,504 | 2,428 |
| Earnings per share | 147.65 | 200.31 | 262.24 | 376.87 | 371.44 | 257.31 | 65.43 | 299.27 | 314.04 | 462.13 | 624.75 | 528.78 | 593.22 | 191.91 |
| Dividend per share | 10 | 10 | 15 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |